tiletamine hydrochloride has been researched along with metallothionein in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, L; Liang, G; Liu, Q; McClung, K; Pan, Y; Sun, J; Sun, W; Tan, Y; Wang, Y; Zhao, Y; Zhou, S | 1 |
1 other study(ies) available for tiletamine hydrochloride and metallothionein
Article | Year |
---|---|
Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
Topics: Animals; Apoptosis; Benzylidene Compounds; Blood Pressure; Blotting, Western; Coloring Agents; Curcumin; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Endoplasmic Reticulum Stress; Fibrosis; Heart; JNK Mitogen-Activated Protein Kinases; Lipid Peroxidation; Male; Metallothionein; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress; Phosphorylation; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction | 2014 |